SCHEMBL6442363

SCHEMBL6442363

COc1cc2c(cc1OC)C1CCCCC1N=C2c1cc2ccccc2s1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 1/20 0.39
FYN P06241 1/20 0.38
HCRTR1 O43613 2/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
GLA P06280 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
KMT2A Q03164 1/20 0.36
ERN1 O75460 1/20 0.36
TNFRSF1A P19438 4/20 0.35
PFKFB3 Q16875 1/20 0.35
HCRTR2 O43614 1/20 0.35
ADRA2A P08913 1/20 0.35
ADRA2C P18825 1/20 0.35
PGK1 P00558 1/20 0.34
PDE4D Q08499 1/20 0.34
NAMPT P43490 1/20 0.34
AVPR1A P37288 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6442359 1.00 S1PR1 (0.39) S1PR1FYNHCRTR1KDM4EMEN1
SCHEMBL6442355 1.00 S1PR1 (0.39) S1PR1FYNHCRTR1KDM4EMEN1
SCHEMBL6450454 0.81 PDE4D (0.38) KDM4EMEN1ALDH1A1GAAMAPT
SCHEMBL6450452 0.81 PDE4D (0.38) KDM4EMEN1ALDH1A1GAAMAPT
SCHEMBL6450450 0.81 PDE4D (0.38) KDM4EMEN1ALDH1A1GAAMAPT
SCHEMBL6449710 0.80 RPS6KB2 (0.41) KDM4EMEN1ALDH1A1GLAGAA
SCHEMBL6449709 0.80 RPS6KB2 (0.41) KDM4EMEN1ALDH1A1GLAGAA
SCHEMBL6449706 0.80 RPS6KB2 (0.41) KDM4EMEN1ALDH1A1GLAGAA
SCHEMBL5972857 0.79 MAPK10 (0.43) MEN1ALDH1A1KMT2AERN1PDE4D
SCHEMBL5972862 0.79 MAPK10 (0.43) MEN1ALDH1A1KMT2AERN1PDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1303506-B1 6-HETEROARYLPHENANTHRIDINES ALTANA PHARMA AG (DE) 2005-02-02 EP claimed
US-6884802-B2 6-heteroarylphenanthridines ALTANA PHARMA AG (DE) 2005-04-26 US disclosed
EP-1303506-B1 6-HETEROARYLPHENANTHRIDINES ALTANA PHARMA AG (DE) 2005-02-02 EP disclosed
US-20040038979-A1 Treating airway disorders such as asthma. ALTANA PHARMA AG (DE) 2004-02-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040038979-A1 Treating airway disorders such as asthma. PTGER4, PDE4B, PDE4A S1PR1 437/4885FYN 2094/4885HCRTR1 1219/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.